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Purpose: There is currently little evidence to support intravenous 
immune globulin (IVIG) therapy for pediatric myocarditis. The purpose 
of our retrospective study was to assess the effects of IVIG therapy 
in patients with presumed myocarditis on survival and recovery of 
ventricular function and to determine the factors associated with its 
poor outcome. 
Methods: We reviewed all consecutive cases of patients with myocarditis 
with left ventricular dysfunction verified by echocardiogram who had 
visited 3 university hospitals between January 2000 and September 
2009. These patients were divided into 2 groups. Group 1 consisted of 
23 patients (69.6%) who received IVIG alone or IVIG in combination 
with steroids, and group 2 consisted of 10 patients (30.3%) who 
received neither IVIG nor other immunosuppressive agents. Clinical 
manifestations, laboratory results, echocardiographic findings, and 
outcomes were compared between these 2 groups. 
Results: One year after the initial presentation, the difference in the 
probability of survival did not show statistical significance in IVIG-
treated patients (P=0.607). Of the echocardiographic parameters 
on admission, a shortening fraction of less than 15% was associated 
with unremitting cardiac failure. Furthermore, anemic patients were 
more likely to have elevated N-terminal fragment levels of the B-type 
natriuretic peptide (NT-proBNP) in the progressed group (P=0.036). 
Conclusion: There was no difference between the IVIG-treated 
patients and the control patients in the degree of recovery of left 
ventricular function and survival. Prospective, randomized, clinical 
studies are needed to elucidate the effects of IVIG treatment during the 
acute stage of myocarditis on ultimate outcomes. 
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Introduction
The clinical presentations of myocarditis range from nonspecific 
systemic symptoms associated with viral prodrome to fulminant 
hemodynamic collapse and sudden death. The extreme diversity of 
clinical manifestations has made the true incidence of myocarditis 
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difficult to determine. Recent prospective postmortem data have 
implicated myocarditis in the sudden death of young adults at rates 
of 8.6% to 12%
1, 2).
Our current understanding of the pathogenesis of myocarditis 
derives largely from animal modes. Direct myocardial invasion 
by cardiotropic virus rapidly progress to the second phase of 
immunologic activation. The use of immunosuppression during 
acute viral myocarditis remains controversial
3, 4). Lernel
5-7) suggested 
that steroids be avoided at least during the first 10 days of acute 
infection because steroids inhibit interferon synthesis and increase 
viral multiplication in experimental coxsackievirus infection. In 
contrast, in experimental coxsackievirus-induced myocarditis, 
virus titers in the heart of polyclonal mouse immune globuline 
(Ig) treated animals were significantly reduced on 7 days after 
infection
8).
However, a few Korean reports have been published on pediatric 
myocarditis regarding the effectiveness of intravenous immune 
globulin (IVIG) treatment. Therefore, we have described the clinical 
outcomes of pediatric patients with myocarditis and compared the 
final outcomes, and the time to recovery of normal left ventricular 
systolic function in those children treated with IVIG, compared 
with those treated neither with IVIG nor other immunosuppressive 
agents. Furthermore, we determined the factors associated with its 
poor outcome.
Materials and methods
1. Patients
We retrospectively analyzed the medical records of 33 myo-
carditis patients who were admitted to the pediatric departments 
of Eulji University School of Medicine, Daejeon, Soonchunhyang 
University School of Medicine, Cheonan and Chungnam 
University School of Medicine, Daejeon. 
The diagnosis of acute viral myocarditis was defined as the 
clinical evidence of acute myocardial dysfunction by physical 
exam, chest X-ray, electrocardiogram (ECG) and echocardiogram 
associated with an elevation of cardiac enzymes such as MB isoform 
of creatine kinase (CK-MB), cardiac troponin T, troponin I and 
N-terminal fragment of B-type natriuretic peptide (NT-proBNP). 
We excluded patients with a history of chronic renal failure and 
evidence of long-standing dilated cardiomyopathy by history or 
physical examination; those with documentation of conditions 
known to be associated with acute congestive heart failure such as 
sepsis, Kawasaki disease and those who received previous treatment 
with a known cardiotoxic agent.
2. Methods
Cardiomegaly on chest X-ray was defined when the cardio-
thoracic (CT) ratio >50% in children more than 1 year old 
and CT ratio >60% in infants younger than 12 months of age. 
Abnormalities on ECG that were recorded were arrhythmia, low 
voltage QRS, ST segment and T wave changes. Measurements 
of left ventricular dimension and function were derived from 
two-dimensional images in the parasternal long-axis view. The 
echocardiographic examination was used to evaluate the valve 
regurgitation, quantitative cardiac contractile function, as well 
as the presence of pericardial fluid. Left ventricular end-diastolic 
(LVED) dimension, left ventricular end-systolic (LVES) dimension 
were measured and calculated to the body surface area. Normal 
dimensions were defined as within two standard deviation (SD)s of 
the mean
9). Normal fractional shortening was 28-35%.
In all cases of suspected myocarditis, bacterial cultures from the 
blood, urine or throat were performed and the antibody titer of 
cardiotropic virus was measured in serums from the 12 patients. 
The cases were considered to have tested positive for the virus 
when the antibody titer increased to more than quadruple. Reverse 
transcriptase-polymerase chain reaction (PCR) was used to evaluate 
RSV, influenza A, influenza B, adenovirus, HSV and EBV through 
tracheal aspirates from 9 patients with respiratory symptoms. In one 
patient, a right ventricular endomyocardial biopsy was performed.
Several factors were compared between group 1 and group 2, 
such as gender, clinical manifestation, days of ICU admission and 
intubation care the laboratory findings, ECG and echocardiogram 
on admission. We also compared the progressed group (including 
mortality and dilated cardiomyopathy) with the recovery group 
according to the long-term follow up results. 
3. Statistical analysis
All the results were expressed as mean value±SD, except when 
stated otherwise. Between the groups, analysis of categorical 
variables was performed with the two-tailed Fisher’s exact test. 
Student’s t-test used to analyze the continuous variables. Survival 
curves were generated according to the Kaplan-Meir method and 
were compared using the log-rank statistics. Multivariate analysis 
was performed using the Cox proportional-hazards model for 
censored data. 
Results
1. Baseline patient characteristics 
The myocarditis group included 18 males and 15 females with a 
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to 19 years. The mean age on admission was 41 months in group 1 
and 60 months in group 2. The mean follow up duration was 13.5 
months and 13.1 months respectively. 
The most common chief complaints were tachycarida and 
respiratory difficulty in 14 patients (42.4%). Poor appetite, lethargy 
and chest pains were the next chief complaints. Newborns or 
infants presented with respiratory distress, cyanosis and heart 
failure. Older patients were initially seen with sudden onset of 
arrhythmia and chest pain. Recent upper respiratory tract infection 
was associated with in 72% of the patients and 45% of the patients 
showed high temperature on admission (Table 1).
2. Chest radiograph, ECG and echocardiogram
The cardiomegaly was seen in 87% of the patients and there was 
no difference between the two groups. ECG was performed in 31 
patients. Major abnormal ECG were low voltage QRS (12.9%), 
sinus tachycardia (12.9%) and complete heart block (6.4%). The 
two patients with third-degree AV block were in group 1 and 
one case transformed to ventricular tachycardia requiring DC 
cardioversion. This ECG finding changed to first degree AV block 
on hospital day 4 and the other patient completely recovered 
from the third-degree AV block. Atrial tachycardia (6.4%) and 
ventricular tachycardia (6.4%) was present in group 1. There was no 
difference between the two groups.
An echocardiography was performed upon admission on all 
patients. At presentation, 24 (72.7%) of the patients had depressed 
left ventricular contractility. The mean FS on admission was 
19±11.3% in group 1 and 20±12.2% in group 2 (P=0.893). 
The mitral valve was the most frequently affected valve and the 
tricuspid valve was next. There was no difference between the two 
groups in the presence of moderate valve insufficiency. Pericardial 
effusion was present in 39% of the patients and 5 cases necessitated 
pericardiocentesis due to cardiac tamponade (Table 2).
3. Laboratory findings
CK-MB was checked in 77% of the patients. The mean CK-MB 
level was 139.7 ng/dL in group 1 and 96 ng/dL in group 2. There 
was no difference between two groups (P=0.751). Troponin I was 
measured in 13 cases and was elevated in 38.4% of the patients. The 
mean cardiac troponin I (cTnI) was 14.7 ng/dL in group 1 and 2.5 
ng/dL in group 2. cTnI was more elevated in IVIG-treated group 
although there was no statistical significance (P=0.207). Troponin 
T was checked in 25 cases and was elevated in 60% of the patients. 
The mean cardiac troponin T (cTnT) level was 1.19 mg/dL in group 
1 and 0.69 mg/dL in group 2. There was no difference between two 
groups (P=0.525).
We measured NT-proBNP in 23 cases and the concentrations 
of NT-proBNP was elevated in 95.6% of patients. The mean 
concentration of NT-proBNP was 16,126 pg/mL in group 1 and 
4,263 pg/mL in group 2 (P=0.019). C-reactive protein (CRP) 
Table 1. General Presentation of Characteristics and Chief Complaints 
(N=33)
No. of patients (%)
Acute presentation (<2 weeks)                           
Infectious prodrome including fever                     
Chief complaint
  Tachypnea / dyspnea                                 
  Lethargic appearance/decreased activity              
  Seizure                                               
  Chest pain                                            
  Cyanosis                                             
  Vomiting with abdominal pain                     
32 (96.9)
24 (72.7)
14 (42.4)
  6 (18.1)
  2 (  6.0)
  6 (18.1)
  2 (  6.0)
  3 (  9.0)
Table 2. Incidence of Specific Cardiovascular Features at Presentation
No. of patients (%)
Mechanical ventilation required           
  Arrhythmia
  ventricular tachycardia                 
  3rd degree AV block                   
  atrial tachycardia                       
  PSVT                                  
  low voltage                            
  premature ventricular contraction       
  sinus tachycardia                       
  ST-T wave changes                    
  WPW syndrome                        
Echocardiogram
  decreased shortening fraction(<28%)    
  dilated left ventricle                    
  pulmonary hypertension                
  pericardial effusion with cardiac tamponade
15 (45.4)
  2 (  6.4)
  2 (  6.4)
  2 (  6.4)
  3 (  9.6)
  4 (12.8)
  2 (  6.4) 
  4 (12.8)
  8 (25.8)
  1 (  3.2)
24 (72.7)
25 (75.7)
  8 (24.2)
  5 (15.1)
Abbreviations: PSVT, paroxysmal supraventricular tachycardia; WPW 
syndrome, Wolff-Parkinson-White syndrome
Table 3. Comparability at Baseline for Conventional Therapy with and 
without IVIG
IVIG 
treatment
No IVIG 
treatment
P 
value
Male*
Age (month)
†
Need for intubation*
ICU (intensive care unit) stay (day)
Captopril/Enalapril treatment*
Intravenous inotropes*
Lowest pH
†
Lowest serum bicarbonate
†
Lowest Hb
†
Highest NT-proBNP
†
Highest C-reactive protein
†
Time from symptoms to admission (day)
12/23 (52.1)
      41±53
11/23 (47.8)
7.7±8.6
11/23 (47.8)
19/23 (82.6)
7.21±0.2
16.7±7.6
9.7±1.5
16126±15483
11.1±18.3
2.2±1.7
6/10 (60.0)
60±88
4/10 (40.0)
4.5±7.2
6/10 (60.0)
6/10 (60.0)
7.22±0.2
13.7±7.0
11.6±1.5
 4263±6907
0.6±0.75
1.8±1.9
0.50
0.72
0.72
0.33
0.70
0.20
0.95
0.36
0.004
0.019
0.015
0.499
*Values are no. of patients (%)
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was significantly elevated in group 1 (P=0.015), and the mean 
concentration of CRP was 11.1 mg/dL in group 1 and 0.6 mg/dL 
in group 2. 
The presence of anemia in conjunction with myocarditis 
occurred 57.9% of the patients. The proportion of patients with 
anemia was significantly higher in IVIG-treated patients (P=0.004). 
Packed red blood cell transfusion was required in 7 cases in group 1 
and none in group 2 (Table 3). 
4. Diagnostic evaluation
Among the 33 patients suspected myocarditis, none of the cases 
showed positive results by bacterial culture of blood, urine, sputum 
or throat. Fourteen out of 21 cases (66.6%) were positive in viral 
study in serum, stool, pericardial fluid and tracheal aspirate. An 
increase in type-specific neutralizing antibodies was found in 5 
cases in coxsackie B3, 4 and 5 viruses. Coxsackie A virus (type 2, 
5 and 16) was identified in serologic techniques in 3 cases. For the 
rest, positive mumps IgM (1 case), positive adenovirus IgM (1 case), 
and high antibody titer of echovirus type 7 (2 cases) were identified 
by serologic technique. Respiratory syncytial virus (5 cases), 
influenza A (1 case), influenza B (1 case), and metapneumovirus 
(1 case) were detected by multiplex RT-PCR in tracheal aspirates 
(Table 4). Endomyocardial biopsy was performed in 1 DCM 
patient under fluoroscopic guidance by percutaneous puncture 
of the right jugular vein; four specimens were obtained from the 
right ventricular septum. Histology of biopsy revealed focal loss of 
myofibril and infiltration of myofibril in the interstitium.  
 
5. Treatment of myocarditis  
Of the 33 children with acute myocarditis, 23 (69.6%) patients 
were treated with high-dose IVIG and 10 (30.3%) were control 
patients who did not receive IVIG therapy.
Seventeen patients received treatment with IVIG (2 g/kg/day) 
and 6 patients received IVIG and steroids (methylpredisolone, 2 
mg/kg/day). In the latter cases, steroids were used for the treatment 
of associated bronchiolitis. Therefore, we added steroids with a 
low dose after the fever subsided. Positive inotropic agents, such 
as dopamine or dobutamine, were used in 19 cases (82.6%) in the 
IVIG-treated groups. Patients receiving IVIG therapy were more 
likely to have received inotropic agents. However, the result did not 
achieve statistical experience (P=0.20). Children in the two groups 
did not differ significantly in sex distribution, age at presentation, 
the use of angiotensin converting enzyme (ACE) inhibitor, or the 
need for ventilator care (Table 3).
 
6. Prediction of 1-year survival
Among the 23 children in the IVIG-treatment group, 3 patients 
died. 17 month-old girl supported on extracorporeal membrane 
oxygenation (ECMO) on hospital day 4 expired due to multiorgan 
failure on hospital day 12. The rest two patients presented as 
fulminant myocarditis expired on hospital day 2. Two patients 
progressed DCM required prolonged antiarrhythmic agent for a 
persistent ventricular arrhythmia, associated with poor ventricular 
function.
Among the 10 patients in the non-IVIG group, 2 patients expired 
due to ventricular tachycardia on hospital day 1 and 7 respectively. 
One patient progressed to DCM and was transplanted at another 
hospital.
The overall survival rate was 81.8%. There was no difference 
in survival at 1 year after presentation between the IVIG-treated 
group and the control group (P=0.607). The recovery of myocardits 
was defined as normal ventricular function by echocardiography 
and the normal values of cardiac enzymes. The mean time to 
recovery of function was 68 days in group 1 and 33 days in group 2. 
There was no significant difference between the groups (P=0.485).
7. Risk factors for adverse outcome
Patients were divided in two groups with based on outcomes. 
One of the groups was the recovery group and the other was the 
progressed group. The number of non-survivors was 5 from a total 
33 of patients (15.1%). Three cases progressed to DCM (9.0%). We 
Table 4. Etiologic Agents Identified from the 14 Cases of Myocarditis
Virus N Source/Method
Influenza A
Influenza B
Mycoplasma pneumoniae
Respiratory syncytial virus
Metapneumovirus
Coxsackievirus A
Coxsackievirus B
Mumps virus
Echovirus type 7
Adenovirus
Rhinovirus
1
1
1
5
1
3
5
1
2
1
1
by complement fixation from blood
by PCR form nasal aspirate
by rise in titer from blood 
positive PCR from tracheal aspirate
positive PCR from tracheal aspirate
by rise in titer from blood
by rise in titer from blood
IgM(+) in blood
by rise in titer from blood
by positive PCR in throat swab
positive culture from nasopharyngeal swab
Table 5. Predictive Factors at Admission for Poor Outcome
Unremitting severe
cardiac failure (N=8)
Clinical recovery
(N=25)
P value
Arrhythmia
Shortening fraction <15%
Increased LVEDD 
Moderate to severe MR
Pulmonary hypertension
Highest NT-proBNP
 5/8 (62.5%)
 8/8 ( 100%)
 8/8 ( 100%)
 4/8 (   50%)
 4/8 (   50%)
28817±12364
  8/25 (32%)
  7/25 (28%)
18/25 (72%)
  9/25 (36%)
  5/25 (20%)
9084±12521
0.213
0.001
0.154
0.681
0.170
0.009
Abbreviations: LVEDD, left ventricular end-diastolic dimension; MR, mitral 
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compared the progressed group (including mortality and dilated 
cardiomyopathy; 8 patients) with the recovery group (25 patients) 
to assess poor prognostic factor (Table 5). 
The mean shortening fraction on admission of the patients who 
developed unremitting cardiac failure was 9.7±3.0%, com  pared to 
23.1±11.2% of those who later recovered cardiac function (P=0.003). 
The mean concentration of NT-proBNP was 28,817±12,364 pg/
mL in unremitting severe cardiac failure, compared to 9,084 
±12,521 pg/mL in the clinical recovery group (P=0.009). Other 
variables examined for possible association with outcomes were 
CRP, hemoglobin, troponin T, and troponin I. None of these 
were significantly associated with outcomes. The treatment with 
inotropic agents or ACE inhibitors did not affect the mortality rate.
The abnormal ECG findings of the progressed group were found 
in 62.5% of the patients compared to 32% in the recovery group. 
However, there was no statistical significance between the two 
groups (Table 6). 
Discussion
Myocarditis is a process characterized by inflammatory infiltrate 
of the myocardium with the necrosis and/or degeneration of 
adjacent myocytes associated with autoimmunity. The true 
incidence of myocarditis is not known because of the variable 
clinical manifestations, laboratory findings and etiologies. Viral 
exposure leads to an acute or subacute immune response that 
is responsible for most of the inflammation, infiltration, and 
myocardial damage that ensues. However, if host immune 
activation continues unabated despite elimination of the virus, 
autoimmune disease may result. Some remodeling mechanisms 
leading to dilated cardiomyopathy may be specific to myocarditis. 
Genetic susceptibility of host was also associated with that immune 
response
10). 
Presentation depends on the age of the child. Newborns or 
infants present with fever, poor appetite, respiratory distress and 
periodic episodes of pallor. Older children and adolescents report 
chest pain, palpitations or sudden-onset arrhythmia. We analyzed 
the clinical findings of the recovery and the progressed groups 
and compared the two  groups. Tacypnea and dyspnea were 
more common in the progressed group, although there was not a 
significant difference (Table 7).
Amsel et al
11) described a 3-month old infant who developed 
myocarditis several hours after diphtheria, pertussis, and tetanus 
(DPT) vaccination. The time of occurrence of symptoms, the 
clinical course, and the negative virological studies suggested a 
possible cardiogenic adverse reaction to the vaccine. In our study, 
a 2-month old girl presented with irritability and decreased oral 
intake 1 day after DPT vaccination. However, there was limitation 
to confirm the vaccination-induced mypocarditis because the 
etiologic agent was not identified in our study.
Fulminant myocarditis was diagnosed on the basis of clinical 
features at presentation, including the presence of severe hemo-
dynamic compromise, rapid onset of symptoms, and fever. In our 
study, 4 patients met the criteria for fulminant myocarditis. One 
patient completely recovered ventricular function and the other 
3 patients died. Despite the fact that the time from onset of the 
symptoms to hospital admission was one or two days, the patients 
with fulminant myocarditis were critically ill at presentation. Three 
patients with fulminant myocarditis suddenly expired between 
12 and 24 hours of their hospital visit. Two of these patients had 
evidence of atrial tachycardia on ECG. 
Most cases of myocarditis result from viral infections. The 
most common viral causes include adenovirus and enterovirus 
(coxsackievirus A and B, echovirus). Although infections are often 
asymptomatic, approximately 5% to 10% of pediatric respiratory 
infections are due to adenovirus infections, with outbreaks 
facilitated in environments where young people remain in close 
proximity
12). 
Tracheal aspirate PCR may provide a safer means of arriving at 
Table 6. Arrhythmia in Patients with Myocarditis
Unremitting severe
cardiac failure (N=8)
Clinical recovery 
(N=25)
Ventricular tachycardia
Atrial tachycardia
3rd degree AV block
PSVT
Premature ventricular contraction
WPW syndrome
1st degree AV block
Total
2
2
0
0
0
1
0
5/8 (62.5%)
0
0
2
3
2
0
1
8/25 (32%)
Abbreviations: PSVT, paroxysmal supraventricular tachycardia; WPW 
syndrome, Wolff-Parkinson-White syndrome
Table 7. Comparison of Chief Complaints between Progressed Group 
and Recovery Group at Admission Day
Chief complaints
cardiac failiure 
(N=8) 
Unremitting severe 
Clinical recovery
(N=25)
P vlaue
Fever 
Tachypnea/dyspnea 
Lethargy
Chest pain
Abdominal pain, vomiting
Cyanosis
Seizure
3 (30.0)
5 (50.0)
2 (20.0)
0
0
0
1 (12.5)
12 (52.1)
  9 (39.1)
  4 (17.3)
  6 (26.0)
  3 (13.0)
  2 (  8.6)
  1 (  4.0)
0.699
0.182
0.456
0.160
0.422
0.568
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an etiologic diagnosis in viral myocarditis than endomyocardial 
biopsy, especially when the right ventricular free wall and outflow 
tracts are pathologically thinned
13). All cases of myocarditis in 
which biopsies were performed had PCR results of heart specimens 
identical to the results of tracheal aspirate screening.
Considerable data is available to demonstrate that enteroviruses 
can be detected within the myocardium of patients with acute 
onset of myocarditis and in mice infected with coxsackievirus. 
Virus infection has also been associated with direct myocytopathic 
effects
14-16). Altogether, the evidence suggests that both the direct 
effects of myocardial infection and the activation of the immune 
process are likely to have significant roles in the development of 
myocarditis.
ECG findings in patients with acute myocardits are highly 
variable. The most typical findings are: 1) sinus tachycardia; 
2) low voltage QRS in standard and precordial leads; and 3) 
flattened or inverted T waves. Friedman and colleagues reported 
significant residual ventricular arrhythmias requiring medication 
in 42% of their patients at a mean follow up period of 51 months, 
and histologic resolution did not correlate with resolution of 
arrhythmia
17). Whether chronicity of the arrhythmia is due to 
fibrosis and scarring as a residual effect of the initial insult or is due 
to undetected persistent inflammation is speculative. In our study, 
2 of 31 (6.4%) patients developed complete heart block. At follow-
up, both of them showed normal ECG on Holter monitoring. One 
patient with persistent ectopic atrial tachycarida was on medication 
(sotalol, propranolol). 
In patients with clinically suspected myocarditis, laboratory 
variables conventionally used to detect myocardial cell damage, 
such as CK or CK-MB levels, are often within the normal range, 
partly because they are present in normal serum and a small 
amount of myocardial necrosis does not lead to increases that exceed 
the normal range. Recently, cardiac troponin T (cTnT), unique 
to cardiac tissue is used to screen myocarditis. When elevated 
cTnT levels were detected in patients with clinically suspected 
myocarditis, immunohistologic analysis of the endomyocardial 
biopsy specimens showed evidence of myocarditis in 93%
18). In our 
study, elevated cTnT was observed in 15 of 25 (60%) of the patients.
Echocardiography is currently recommended in the initial 
diagnostic evaluation of all patients with suspected myocarditis. 
However, the most common echocardiographic features of 
acute myocarditis are quite nonspecific. Segmental wall motion 
abnormalities were observed in 64% of patients and included 
hypokinetic, akinetic, or dyskinetic regions
19). James et al
20) reported 
that lymphocytic myocarditis was associated with LV diastolic 
dysfunction of a predominantly restrictive pattern. Myocarditis 
and fibrosis induced changes in echocardiographic image texture, 
i.e. increases in brightness, heterogeneity, and contrast
21). Typically, 
patients with fulminant myocarditis presented with nondilated, 
thickened and hypocontractile LVs, whereas those with acute 
myocarditis had marked LV dilation, normal LV thickness and 
decreased LV function
22).
In our study, 8 patients met the criteria for pulmonary hyper-
tension by echocardiography. Of those, 2 patients expired, one 
patient progressed to DCM, and the rest of patients recovered 
ventricular function at the time of discharge. Cappola et al
23) 
reported that the mean pulmonary artery is particularly important 
for stratifying risk in myocarditis. Our study did not show the 
pulmonary hypertension as the poor prognostic factor (P=0.17). 
However, these results should not be generalized due to the small 
samples in our study.
Because there is a risk associated with biopsy, particularly in 
young children or those with severe ventricular dilatation, many 
centers tried to find etiology of acute myocarditis in another way. 
Viral culture of peripheral specimens, such as blood, stool, or 
urine is commonly performed but is unreliable at identifying the 
causative infection. A fourfold increase in antibody titer correlates 
with infection. 
The clinical utility of endomyocardial biopsy for evaluating 
patients with possible myocarditis has been debated
24). Nevertheless, 
endomyocardial biopsy continues to be selectively used in many 
centers for the evaluation of possible myocarditis. Cardiovascular 
magnetic resonance (CMR) may be a valuable tool to noninvasively 
identify and assess the extent of myocardial involvement before 
endomyocardial biopsy is performed. PCR amplified viral 
genome in 239 of 624 (38%) samples obtained from patients with 
myocarditis in the previous study
25). Pankuweit et al
26) confirmed 
the prevalence of parvovirus B19 genome in endomyocardial biopsy 
to be highest in patients with myocarditis (19%).
The diagnostic complexity created by the multifaceted path-
ophysiology of continued viral presence might best be deciphered 
by cDNA microarray analysis of the message from endomyocardial 
biopsy tissue in the near future. 
In this study, the lower hemoglobin level, the higher the NT-
proBNP level in the progressed group. Levels of BNP are used 
to facilitate the diagnosis of heart failure and to determine the 
prognosis in patients with heart failure and myocardial infarction 
in adults
27-29). Recently, the use of NT-proBNP was extended to 
pediatric inflammatory heart disease or congenital heart disease. 
However, the association between anemia and high NT-proBNP 
in acute myocardits is unknown. Rall et al
30) reported that anemia 
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failure. A reduced hematocrit can result not only from a reduced 
red blood cell volume but also from an increased plasma volume. 
Volume overload that occurs with hemodilution could also 
contribute to the worse outcomes
31).
Previous studies attempted to describe the clinical course of acute 
myocarditis in pediatric patients. Predictive factors on admission 
for poor outcome were ejection fraction <30%, increased left 
ventricular end-diastolic dimension and moderate to severe mitral 
regurgitation
32). In our study, NT-proBNP concentrations and left 
ventricular fractional shortening were valuable prognostic factors. 
The existence of moderate mitral regurgitation or pulmonary 
hypertension did not affect the mortality in this study.
Understanding the pathogenesis of myocarditis provided the 
question of whether there is sufficient scientific evidence to support 
or discourage the use of IVIG or steroids. According to a recent 
study in Korea, steroids and IVIG were ineffective treatments in 
acute myocarditis
33). In the study by Drucker et al
34), 21 children 
presenting with presumed acute viral myocarditis were treated 
with an IVIG (2 g/kg/day). These findings resulted in a higher 
probability of left ventricular recovery for the immune globulin-
treated patients. Kim et al
35) reported two children with fulminant 
myocarditis successfully treated with a 10-h infusion of high dose 
IVIG. The mechanism by which IVIG may improve myocardial 
dysfunction in myocarditis is unknown. IVIG could be effective 
by providing specific antibodies to viruses and thus could lead to a 
more rapid clearing of myocardial viral infection.
Despite the potential therapeutic efficacy suggested by previous 
uncontrolled studies, treatment of adult patients with recent-onset 
cardiomyopathy with immune globulin in placebo-controlled trial 
did not affect improvements in LVEF or functional capacity during 
follow-up
36). In this study, there was no difference between the 
immune globulin-treated patients and the control patients in the 
degree of recovery and survival. The efficacy of immunosuppressive 
therapy for acute myocarditis in children requires investigation with 
a prospective, randomized, and controlled study. Further studies 
should identify the clinical predictor or genetic basis of myocarditis 
progressing DCM.
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